NCT07596888 IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study Status NOT_YET_RECRUITING Phase PHASE1
NCT07579546 PERsistance of Long-Acting inJEctable CAB+RPV in a Cohort of Virologically-suppressed PLWH: a Real-life Study Status NOT_YET_RECRUITING Phase N/A
NCT07357584 Efficacy and Safety of Doravirine in the Rapid Initiation Status NOT_YET_RECRUITING Phase PHASE4
NCT07293559 Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States Status RECRUITING Phase N/A
NCT07081763 Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption Status NOT_YET_RECRUITING Phase PHASE2
NCT07080138 Research on the Psychological Status of Patients With HIV-1 Infection Status NOT_YET_RECRUITING Phase N/A
NCT07055451 Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06987318 A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection Status NOT_YET_RECRUITING Phase PHASE1
NCT06919016 A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06905275 A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV Status SUSPENDED Phase PHASE1
NCT06774872 Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully Status RECRUITING Phase PHASE2
NCT06762054 Investigating the Optimal Management of Dolutegravir Resistance Status RECRUITING Phase N/A
NCT06749054 Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children Status RECRUITING Phase PHASE2
NCT06747507 Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance Status RECRUITING Phase PHASE3
NCT06661317 Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens. Status NOT_YET_RECRUITING Phase N/A